» Articles » PMID: 22859936

The -2518A/G Polymorphism in the MCP-1 Gene and Tuberculosis Risk: a Meta-analysis

Overview
Journal PLoS One
Date 2012 Aug 4
PMID 22859936
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The -2518A/G polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene has been implicated in the susceptibility to tuberculosis (TB), but the results are not conclusive. The aim of this study is to investigate the association between the -2518A/G polymorphism in the MCP-1 gene and the risk of tuberculosis by meta-analysis.

Methods: We searched Pubmed, Embase, CNKI and Wanfang databases, covering all studies until April 29(th), 2011. Statistical analyses were performed using the Revman4.2 and STATA10.0 software.

Results: A total of 5341 cases and 6075 controls in 13 case-control studies were included in the meta-analysis. The results indicated that the GG homozygote carriers had a 67% increased risk of TB compared with the A allele carriers (GG vs. GA+AA: OR = 1.67, 95%CI = 1.25-2.23, P = 0.0006). In the subgroup analysis by ethnicity, significant elevated risks were found in Asians and Latinos, but not in Africans (GG vs. GA+AA: OR = 1.79, 95%CI = 1.19-2.70 and P = 0.005 for Asians; OR = 2.15, 95%CI = 1.32-3.51 and P = 0.002 for Latinos; OR = 1.28, 95%CI = 0.45-3.64 and P = 0.65 for Africans).

Conclusion: This meta-analysis suggested that the -2518A/G polymorphism of MCP-1 gene would be a risk factor for TB in Asians and Latinos, while not in Africans.

Citing Articles

Cytokine/chemokine profiles in people with recent infection by .

Herrera M, Keynan Y, Lopez L, Marin D, Velez L, McLaren P Front Immunol. 2023; 14:1129398.

PMID: 37261336 PMC: 10229054. DOI: 10.3389/fimmu.2023.1129398.


Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations.

Taghavi Y, Hassanshahi G, Kounis N, Koniari I, Khorramdelazad H J Cell Commun Signal. 2019; 13(4):451-462.

PMID: 30607767 PMC: 6946768. DOI: 10.1007/s12079-018-00500-8.


Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis.

Liu H, Yang C, Lu W, Zeng Y Medicine (Baltimore). 2018; 97(4):e9702.

PMID: 29369198 PMC: 5794382. DOI: 10.1097/MD.0000000000009702.


Roles of monocyte chemotactic protein 1 and nuclear factor-κB in immune response to spinal tuberculosis in a New Zealand white rabbit model.

Guo X, Bai Z, Qiang B, Bu F, Zhao N Braz J Med Biol Res. 2017; 50(3):e5625.

PMID: 28225889 PMC: 5333719. DOI: 10.1590/1414-431X20165625.


P2X7R Gene Polymorphisms are Associated with Increased Risk of Pulmonary Tuberculosis in the Tibetan Chinese Population.

Zhu X, Guo W, Ren G, He X, Hu Q, Zhang Y Am J Trop Med Hyg. 2016; 95(5):1016-1020.

PMID: 27672203 PMC: 5094209. DOI: 10.4269/ajtmh.16-0056.


References
1.
Yang B, Zhuang B, Li F, Zhang C, Song A . [The relationship between monocyte chemoattractant protein-1 gene polymorphisms and the susceptibility to pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi. 2009; 32(6):454-6. View

2.
Buijtels P, van de Sande W, Parkinson S, Petit P, van der Sande M, van Soolingen D . Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int J Tuberc Lung Dis. 2008; 12(12):1485-8. View

3.
Rosas-Taraco A, Revol A, Salinas-Carmona M, Rendon A, Caballero-Olin G, Arce-Mendoza A . CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis. 2007; 196(11):1698-706. DOI: 10.1086/522147. View

4.
Flores-Villanueva P, Ruiz-Morales J, Song C, Flores L, Jo E, Montano M . A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med. 2005; 202(12):1649-58. PMC: 2212957. DOI: 10.1084/jem.20050126. View

5.
Cooke G, Campbell S, Sillah J, Gustafson P, Bah B, Sirugo G . Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med. 2006; 174(3):339-43. DOI: 10.1164/rccm.200601-088OC. View